Kalgutkar Amit S, Rowlinson Scott W, Crews Brenda C, Marnett Lawrence J
A. B. Hancock, Jr., Memorial Laboratory for Cancer Research, Department of Biochemistry, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Bioorg Med Chem Lett. 2002 Feb 25;12(4):521-4. doi: 10.1016/s0960-894x(01)00792-2.
This paper describes SAR studies involved in the transformation of the NSAID meclofenamic acid into potent and selective cyclooxygenase-2 (COX-2) inhibitors via neutralization of the carboxylate moiety in this nonselective COX inhibitor.
本文描述了通过中和非选择性环氧化酶(COX)抑制剂甲氯芬那酸中的羧基部分,将其转化为强效且选择性的环氧化酶-2(COX-2)抑制剂的构效关系研究。